Himani Chandna
Himani Chandna
CRITIC
img-contested
N/A
0 reviews
PUBLIC
img-contested
N/A
0 reviews

RECENT ARTICLES

Sort by:
No Rating
Top WHO official backs Covaxin, says evidence maybe limited but India has every right to approve

Top WHO official backs Covaxin, says evidence maybe limited but India has every right to approve

Sign inLog into your accountyour usernameyour passwordPassword recoveryRecover your passwordyour emailSign inWelcome! Log into your accountyour usernameyour passwordPassword recoveryRecover your passwordyour emailA password will be e-mailed to you.Text Size:A-A+New Delhi:Also Read:Also Read:an important aspectAEFI national committees (panels formed by different countries to monitor AEFI)Also Read: Subscribe to our channels on &Why news media is in crisis & How you can fix itIndia needs free, fair, non-hyphenated and questioning journalism even more as it faces multiple...

February 22, 2021
Share
Save
Review
No Rating
How many of your colleagues used Ayurveda to treat Covid, IMA asks Harsh Vardhan

How many of your colleagues used Ayurveda to treat Covid, IMA asks Harsh Vardhan

Sign inWelcome! Log into your accountPassword recoveryRecover your passwordA password will be e-mailed to you.Text Size:A-A+New Delhi:The protocol promotes use of ashwagandha, guduchi, pippali, Ayush 64 tablets in different doses, and yoga to prevent Covid, treat mild symptoms and for post-Covid self-care.ThePrint reached a health ministry spokesperson for a comment on the matter via email and text message, but there was no response until the time of publishing this report.Also read:Also read: Support Our JournalismIndia needs fair, non-hyphenated and questioning...

October 8, 2020
Share
Save
Review
No Rating
BCG vaccine trials to begin in 2 weeks on high-risk Covid-19 groups in Maharashtra

BCG vaccine trials to begin in 2 weeks on high-risk Covid-19 groups in Maharashtra

Sign inWelcome! Log into your accountPassword recoveryRecover your passwordA password will be e-mailed to you.Text Size:A-A+New Delhi: India is set to begin trials, within the next two weeks, to determine if the bacille Calmette-Guérin (BCG) vaccine can boost immunity in the fight against Covid-19, Adar Poonawalla, CEO, Serum Institute of India (SII) told ThePrint.The BCG is a vaccine for tuberculosis and is administered at birth in countries such as India, which have historically had a high prevalence of the disease.“We are likely to start the study within two weeks from now to check if...

April 20, 2020
Share
Save
Review
No Rating
Indian drugmakers begin developing remdesivir, ‘world's best shot' against Covid-19

Indian drugmakers begin developing remdesivir, ‘world's best shot' against Covid-19

Sign inWelcome! Log into your accountPassword recoveryRecover your passwordA password will be e-mailed to you.Text Size:A-A+New Delhi:Also read: Also read: Also read:  Support Our JournalismIndia needs fair, non-hyphenated and questioning journalism, packed with on-ground reporting. ThePrint – with exceptional reporters, columnists and editors – is doing just that.Sustaining this needs support from wonderful readers like you.Whether you live in India or overseas, you can take a paid subscription by clicking .Why the drug lords prove the efficacy for CORONA in USA where...

April 22, 2020
Share
Save
Review
  • Total 4 items
  • 1
OUTLETS
theprint.in

theprint.in

CRITIC
img-contested
N/A
PUBLIC
img-contested
N/A